Tuesday, June 12, 2007 9:27:10 AM
Tuesday June 12, 8:00 am ET
EDEN PRAIRIE, Minn., June 12, 2007 (PRIME NEWSWIRE) -- NVE Corporation (NasdaqCM:NVEC - News) announced today that it has been notified by the U.S. Patent and Trademark Office (USPTO) of the expected grant of a patent relating to magneto-thermal and spin-momentum transfer MRAM inventions.
NVE has been notified that the patent, titled ``Thermomagnetically Assisted Spin-Momentum-Transfer Switching Memory,'' will be issued today. The patent is number 7,230,844 and is the grant of a patent under the application published by the USPTO as number 2006-0077707.
Magnetothermal MRAM uses a combination of ultra-fast magnetic fields and heat pulses, both from electrical current. Spin-momentum transfer is a method of changing the spin of storage electrons directly with an electrical current rather than an induced magnetic field. Both technologies may have the potential to reduce the energy required to write data and allow reduction of the memory cell size while maintaining thermal stability.
The grant brings NVE's U.S. patent total to 42. The company has more than 100 patents worldwide issued, pending, or licensed from others. Links to the new patent and NVE's other U.S. patents can be found at the ``About NVE'' section of the company's Website (http://www.nve.com).
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that many experts believe represents the next generation of microelectronics. NVE licenses its MRAM intellectual property and sells spintronic products, including sensors and couplers, to revolutionize data sensing and transmission.
The NVE Corporation logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3120
Statements used in this press release that relate to future plans, events, or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as uncertainties relating to the grant of patents in the future, risks in the enforcement of our patents, risks related to MRAM commercialization, as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K and other reports filed with the SEC.
Contact:
NVE Corporation
Curt A. Reynders, Chief Financial Officer
(952) 829-9217
Source: NVE Corporation
Recent NVEC News
- NVE Schedules Conference Call on Fourth-Quarter and Fiscal Year Results • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:05:16 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 04:26:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:24:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:20:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/24/2024 03:17:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/17/2024 09:11:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:08:54 PM
- NVE Schedules Conference Call on Third-Quarter Results • GlobeNewswire Inc. • 01/10/2024 09:05:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/03/2024 09:05:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/18/2023 08:10:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 08:05:37 PM
- NVE Schedules Conference Call on Second-Quarter Results • GlobeNewswire Inc. • 10/11/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 09:17:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 09:05:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 08:57:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 08:50:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:45:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/19/2023 08:10:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 08:02:49 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/19/2023 08:02:18 PM
- NVE Schedules Conference Call on First-Quarter Results • GlobeNewswire Inc. • 07/12/2023 08:05:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM